NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Activity
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

21 hedge funds and large institutions have $1.32M invested in InVivo Therapeutics Holdings Corp in 2021 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Holders
21
Holders Change
-2
Holders Change %
-8.7%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
6
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
TSS
1
Two Sigma Securities
New York
$31K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$223K
3
TRCT
3
Tower Research Capital (TRC)
New York
$8K
4
ICM
4
IMS Capital Management
Oregon
$14K
5
Millennium Management
5
Millennium Management
New York
$16K

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
VF
2
Virtu Financial
New York
$0
3
Goldman Sachs
3
Goldman Sachs
New York
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$20K
Name Market Value Shares Shares
Change 		Shares
Change %
JCM
26
Jacobi Capital Management
Pennsylvania
$0 1 – –
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
SWM
28
Sugarloaf Wealth Management
Georgia
$0 1 – –
1
2